Clinical Ink Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Clinical Ink Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11417
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clinical Ink Inc (Clinical Ink) is a technology company that offers eSource and patient engagement solutions. The company offers data management solution, monitoring solution, clinical site solution and patient centric solution. It offers SureSource, an eSource platform to capture eSource data and documents electronically at the site. Clinical Ink’s eSource solutions reduce the total cost of clinical trials by providing customized eSource documents. It serves pharmaceutical and medical device companies; academic institutions, and contract research organizations. The company has operations in North Carolina, Pennsylvania and Massachusetts. Clinical Ink is headquartered in Winston-Salem, North Carolina, the US.

Clinical Ink Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clinical Ink Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinical Ink Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clinical Ink Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinical Ink Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Clinical Ink Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clinical Ink Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Clinical Ink Secures USD5.36 Million in Venture Funding 10
Clinical Ink Raises USD9.86 Million in Venture Financing 11
Clinical Ink Raises US$4.3 Million In Series B Financing 12
Private Equity 13
NovaQuest Capital Acquires Majority Stake in Clinical Ink 13
Partnerships 15
Clinical Ink And Clintara Partner For Central Nervous System Clinical Trials 15
Quanticate Partners with Clinical Ink 16
Clinical Ink Inc – Key Competitors 17
Clinical Ink Inc – Key Employees 18
Clinical Ink Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
May 23, 2017: Clinical Ink and endpoint Announce Industry-First Alliance 20
Product News 21
Apr 21, 2017: Clinical Ink Extends eCOA and Risk-Based Monitoring Capabilities 21
Other Significant Developments 22
May 18, 2017: eSource and IRT Integration Simplifies the Site Experience 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Clinical Ink Inc, Medical Equipment, Key Facts 2
Clinical Ink Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Clinical Ink Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinical Ink Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clinical Ink Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinical Ink Inc, Deals By Market, 2012 to YTD 2018 8
Clinical Ink Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clinical Ink Secures USD5.36 Million in Venture Funding 10
Clinical Ink Raises USD9.86 Million in Venture Financing 11
Clinical Ink Raises US$4.3 Million In Series B Financing 12
NovaQuest Capital Acquires Majority Stake in Clinical Ink 13
Clinical Ink And Clintara Partner For Central Nervous System Clinical Trials 15
Quanticate Partners with Clinical Ink 16
Clinical Ink Inc, Key Competitors 17
Clinical Ink Inc, Key Employees 18
Clinical Ink Inc, Other Locations 19

List of Figures
Clinical Ink Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Clinical Ink Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Clinical Ink Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Clinical Ink Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Clinical Ink Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clinical Ink Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Clinical Ink Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clinical Ink Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Clinical Ink Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Esterline Technologies Corporation:戦略・SWOT・企業財務分析
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Webjet Limited:企業の戦略・SWOT・財務情報
    Webjet Limited - Strategy, SWOT and Corporate Finance Report Summary Webjet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Unitil Corp (UTL):企業の財務・戦略的SWOT分析
    Summary Unitil Corp (Unitil) is an interstate electricity and natural gas utility company. The company offers construction, operation and maintenance of gas and electric distribution systems. Unitil offers business operations such as electricity distribution, gas distribution utility operations and …
  • Al Ain Ahlia Insurance Company PSC:企業の戦略・SWOT・財務分析
    Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report Summary Al Ain Ahlia Insurance Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …
  • Sierra Oncology Inc (SRRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • APR Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary APR Energy Ltd (APR), formerly APR Energy plc, is an energy solutions and services provider. The company installs, owns, operates and maintains power plants for applications such as bridging power, distributed power, grid stability and support, emergency power, industrial generation and peak …
  • Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Houston American Energy Corp (Houston American Energy) is an oil and gas company that provides exploration and development services. The company concentrates on development, exploration, …
  • Boardriders, Inc:企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Bayerische Patentallianz GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Bayerische Patentallianz GmbH (Bayerische Patentallianz) is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inv …
  • Groupama Assurances Mutuelles:企業の戦略的SWOT分析
    Groupama Assurances Mutuelles - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Griffon Corporation:企業の戦略・SWOT・財務分析
    Griffon Corporation - Strategy, SWOT and Corporate Finance Report Summary Griffon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ultragenyx Pharmaceutical Inc (RARE):企業の財務・戦略的SWOT分析
    Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • FitLife Brands, Inc.:戦略・SWOT・企業財務分析
    FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and on …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆